Reaction Details Report a problem with these data
Target
Sigma intracellular receptor 2
Ligand
BDBM349522
Substrate
n/a
Meas. Tech.
Competitive Radioligand Binding Assay 2
Ki
21.0±n/a nM
Citation
 Rishton, GM; Catalano, SM; Look, GC Isoindoline compositions and methods for treating neurodegenerative disease US Patent  US10207991 Publication Date 2/19/2019 
Target
Name:
Sigma intracellular receptor 2
Synonyms:
MAC30 | Meningioma-associated protein 30 | S2R | SGMR2_HUMAN | Sigma-2 receptor | Sigma2 receptor | TMEM97 | Transmembrane protein 97
Type:
Protein
Mol. Mass.:
20857.20
Organism:
Homo sapiens (Human)
Description:
Q5BJF2
Residue:
176
Sequence:
MGAPATRRCVEWLLGLYFLSHIPITLFMDLQAVLPRELYPVEFRNLLKWYAKEFKDPLLQEPPAWFKSFLFCELVFQLPFFPIATYAFLKGSCKWIRTPAIIYSVHTMTTLIPILSTFLFEDFSKASGFKGQRPETLHERLTLVSVYAPYLLIPFILLIFMLRSPYYKYEEKRKKK
  
Inhibitor
Name:
BDBM349522
Synonyms:
US10207991, Ex. Cpd. No. 38 | US10611728, Example Compound 38 | US11691947, Example 38
Type:
Small organic molecule
Emp. Form.:
C24H32FNO2
Mol. Mass.:
385.5148
SMILES:
CC(C)Oc1ccc(CC[C@@H](C)N2Cc3ccc(F)cc3C2)cc1OC(C)C |r|
Structure:
Search PDB for entries with ligand similarity: